ADVANTAGES OF HIGH-DOSE INHALED BUDESONIDE

The Lancet

Volumn 331, Issue 8583, 1988, Pages 476-

  Adelroth, Ellinor ^a   Thompson, Sture ^b,c  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b Swedish Institute of Health Economics ^*  (Denmark)

^c KARLSTAD UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE;

ASTHMA; HUMAN; LETTER; PRIORITY JOURNAL;

ADMINISTRATION, INHALATION; ANTI-INFLAMMATORY AGENTS, STEROIDAL; ASTHMA; BUDESONIDE; GLUCOCORTICOIDS; HUMAN; LENGTH OF STAY; PREGNENEDIONES;

EID: 0023874108     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(88)91273-1     Document Type: Letter

References (2)

1. The place of high-dose inhaled corticosteroids in asthma therapy
2. High dose inhaled budesonide in the treatment of severe steroid-dependant asthmatics a two year study